SHR2285

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Atridia Pty Ltd.

Conditions

Healthy VolunteersThrombosis

Phase 1

The PK/PD Study of SHR2285 Tablets in Healthy Subjects

CompletedNCT03769831

Jiangsu HengRui Medicine Co., Ltd.Thrombosis

Start: 2019-02-25End: 2019-07-22Updated: 2021-05-24

A Trial of SHR2285 in Healthy Subjects

CompletedNCT04829305

Atridia Pty Ltd.Healthy Volunteers

Start: 2021-05-20End: 2021-09-06Updated: 2022-03-08

Related Papers

First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects

Frontiers in Pharmacology2022-02-1021 citations